Fraction Unbound in Tissue Formula:
From: | To: |
Fraction Unbound in Tissue is defined as the systemically available fraction of a drug in body tissue. It represents the proportion of drug that is not bound to tissue proteins and is therefore available for pharmacological activity.
The calculator uses the formula:
Where:
Explanation: This formula calculates the fraction of drug that remains unbound in tissue based on plasma unbound fraction, tissue volume, and distribution parameters.
Details: Calculating the fraction unbound in tissue is crucial for understanding drug distribution, predicting pharmacological effects, and determining appropriate dosing regimens. It helps in assessing how much drug is actually available at the target tissue site.
Tips: Enter all values in the appropriate units. Fraction unbound values should be between 0 and 1. Volume values must be positive, and Volume of Distribution must be greater than Plasma Volume.
Q1: What is the significance of fraction unbound in tissue?
A: It indicates the proportion of drug that is free to interact with tissue receptors and produce pharmacological effects, which is critical for understanding drug efficacy and toxicity.
Q2: How does this differ from fraction unbound in plasma?
A: Fraction unbound in plasma refers to drug availability in blood, while fraction unbound in tissue refers to availability in body tissues, which can differ due to tissue-specific binding characteristics.
Q3: What factors affect fraction unbound in tissue?
A: Tissue protein binding, lipid solubility, pH gradients, and tissue blood flow can all influence the fraction of drug that remains unbound in tissues.
Q4: When is this calculation particularly important?
A: This calculation is especially important for drugs that have significant tissue distribution, drugs with narrow therapeutic windows, and when predicting tissue-specific drug effects.
Q5: Are there limitations to this calculation?
A: The calculation assumes homogeneous distribution and may not account for tissue-specific variations in drug binding or metabolic activity.